{"entity":{"type":"insider","cik":"0001761333","url":"/insider/0001761333","json_url":"/insider/0001761333.json","name":"Chow Gregory K.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2019-03-14","last":"2025-10-16","span_basis":"filed_date"},"name_variants":[{"name":"Chow Gregory K.","source":"filing","n_filings":4,"first_seen":"2019-03-14","last_seen":"2025-10-16"}],"transactions":[{"id":4824273,"accession":"0001761333-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001761333-25-000005","line_url":"/filing/0001761333-25-000005#line-1","is_derivative":false,"issuer_cik":"0001382101","issuer_name":"SUTRO BIOPHARMA, INC.","issuer_ticker":"STRO","issuer_name_source":null,"issuer_url":"/issuer/0001382101","owner_cik":"0001761333","owner_name":"Chow Gregory K.","owner_display_name":"Chow Gregory K.","owner_url":"/insider/0001761333","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19750.0,"shares_display":"19,750","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":15997.5,"total_display":"15,997.50","total_whole":"15,998","shares_owned_after":19750.0,"shares_owned_after_display":"19,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-16","scope":"insider"},{"id":2921519,"accession":"0001567619-20-013189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-013189","line_url":"/filing/0001567619-20-013189#line-1","is_derivative":false,"issuer_cik":"0000882361","issuer_name":"Aptose Biosciences Inc.","issuer_ticker":"APTO","issuer_name_source":null,"issuer_url":"/issuer/0000882361","owner_cik":"0001761333","owner_name":"Chow Gregory K.","owner_display_name":"Chow Gregory K.","owner_url":"/insider/0001761333","role":"Officer (Executive VP & CFO)","role_mark":"O","role_mark_label":"Officer (Executive VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & CFO","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126668.0,"shares_display":"126,668","price_per_share":6.05,"price_display":"6.05","price_state":"stated","total_value":766341.4,"total_display":"766,341.40","total_whole":"766,341","shares_owned_after":232846.0,"shares_owned_after_display":"232,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-10","scope":"insider"},{"id":8661553,"accession":"0001567619-19-013037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-013037","line_url":"/filing/0001567619-19-013037#line-1","is_derivative":false,"issuer_cik":"0000882361","issuer_name":"Aptose Biosciences Inc.","issuer_ticker":"APTO","issuer_name_source":null,"issuer_url":"/issuer/0000882361","owner_cik":"0001761333","owner_name":"Chow Gregory K.","owner_display_name":"Chow Gregory K.","owner_url":"/insider/0001761333","role":"Officer (Senior VP & CFO)","role_mark":"O","role_mark_label":"Officer (Senior VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":1.842,"price_display":"1.84","price_state":"stated","total_value":13815.0,"total_display":"13,815.00","total_whole":"13,815","shares_owned_after":134514.0,"shares_owned_after_display":"134,514","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-07","scope":"insider"},{"id":8018173,"accession":"0001567619-19-006894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-19-006894","line_url":"/filing/0001567619-19-006894","is_derivative":false,"issuer_cik":"0000882361","issuer_name":"Aptose Biosciences Inc.","issuer_ticker":"APTO","issuer_name_source":null,"issuer_url":"/issuer/0000882361","owner_cik":"0001761333","owner_name":"Chow Gregory K.","owner_display_name":"Chow Gregory K.","owner_url":"/insider/0001761333","role":"Officer (Senior VP & CFO)","role_mark":"O","role_mark_label":"Officer (Senior VP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & CFO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":1.7548,"price_display":"1.75","price_state":"stated","total_value":26322.0,"total_display":"26,322.00","total_whole":"26,322","shares_owned_after":122014.0,"shares_owned_after_display":"122,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-13","filed_date":"2019-03-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001382101","name":"SUTRO BIOPHARMA, INC.","url":"/issuer/0001382101","role":"Officer (CFO)","n_filings":1,"first_seen":"2025-10-16","last_seen":"2025-10-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000882361","name":"Aptose Biosciences Inc.","url":"/issuer/0000882361","role":"Officer (Executive VP & CFO)","n_filings":3,"first_seen":"2019-03-14","last_seen":"2020-07-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001761333","retrieved_at":"2026-08-22T12:24:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}